Drug intelligence / Profile preview

xin sheng hua granules

Development stage
Unknown
Lead developer
Beijing Yadong Biopharmaceutical
Administration
Oral
01

Overview

Xin Sheng Hua Granules is a Traditional Chinese Medicine (TCM) product developed and manufactured by Beijing Yadong Biopharmaceutical (also known as Beijing ASIA-EAST Biopharmaceutical). It is primarily used in gynecology for postpartum recovery. The formula is a modification of the classic Shenghua Tang, typically containing ingredients such as Angelica sinensis, Ligusticum chuanxiong, and Leonurus japonicus. It functions by promoting blood circulation to resolve blood stasis and nourishing new blood. Clinically, it is indicated for the treatment of postpartum lochia retention, abdominal pain caused by blood stasis, and to assist in uterine involution. The preparation is an approved pharmaceutical product in China, widely utilized in obstetric clinical practice to ensure the complete discharge of postpartum debris and support uterine health.

Brand names
新生化颗粒Xin Sheng Hua Ke Li
Other names
Xinshenghua Granules
02

Targets

NF-κBJAK1 (Janus kinase 1)STAT1 (Signal transducer and activator of transcription protein 1)

Beyond the preview

Go deeper on xin sheng hua granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on xin sheng hua granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call